Pain — Study of Pain Control With Hormonal IUS Insertion
Citation(s)
Ahmad G, Duffy J, Watson AJ Pain relief in hysterosalpingography. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD006106. Review. Update in: Cochrane Database Syst Rev. 2015;9:CD006106.
Allen RH, Bartz D, Grimes DA, Hubacher D, O'Brien P Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007373. doi: 10.1002/14651858.CD007373.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;7:CD007373.
Bednarek PH, Micks EA, Edelman AB, Li H, Jensen JT The effect of nitroprusside on IUD insertion experience in nulliparous women: a pilot study. Contraception. 2013 Apr;87(4):421-5. doi: 10.1016/j.contraception.2012.10.030. Epub 2012 Dec 4.
Finer LB, Jerman J, Kavanaugh ML Changes in use of long-acting contraceptive methods in the United States, 2007-2009. Fertil Steril. 2012 Oct;98(4):893-7. doi: 10.1016/j.fertnstert.2012.06.027. Epub 2012 Jul 13.
Finer LB Unintended pregnancy among U.S. adolescents: accounting for sexual activity. J Adolesc Health. 2010 Sep;47(3):312-4. doi: 10.1016/j.jadohealth.2010.02.002. Epub 2010 Apr 9.
Jensen HH, Blaabjerg J, Lyndrup J [Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion]. Ugeskr Laeger. 1998 Nov 23;160(48):6958-61. Danish.
Karabayirli S, Ayrim AA, Muslu B Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. J Minim Invasive Gynecol. 2012 Sep-Oct;19(5):581-4. doi: 10.1016/j.jmig.2012.04.004. Epub 2012 Jul 4.
Kavanaugh ML, Frohwirth L, Jerman J, Popkin R, Ethier K Long-acting reversible contraception for adolescents and young adults: patient and provider perspectives. J Pediatr Adolesc Gynecol. 2013 Apr;26(2):86-95. doi: 10.1016/j.jpag.2012.10.006. Epub 2012 Dec 31.
Kavanaugh ML, Jerman J, Hubacher D, Kost K, Finer LB Characteristics of women in the United States who use long-acting reversible contraceptive methods. Obstet Gynecol. 2011 Jun;117(6):1349-57. doi: 10.1097/AOG.0b013e31821c47c9.
Massey SE, Varady JC, Henzl MR Pain relief with naproxen following insertion of an intrauterine device. J Reprod Med. 1974 Dec;13(6):226-31.
Mody SK, Kiley J, Rademaker A, Gawron L, Stika C, Hammond C Pain control for intrauterine device insertion: a randomized trial of 1% lidocaine paracervical block. Contraception. 2012 Dec;86(6):704-9. doi: 10.1016/j.contraception.2012.06.004. Epub 2012 Jul 6.
Renner RM, Jensen JT, Nichols MD, Edelman AB Pain control in first-trimester surgical abortion: a systematic review of randomized controlled trials. Contraception. 2010 May;81(5):372-88. doi: 10.1016/j.contraception.2009.12.008. Epub 2010 Jan 27. Review.
Rowbotham MC What is a "clinically meaningful" reduction in pain? Pain. 2001 Nov;94(2):131-2. Review.
Sääv I, Aronsson A, Marions L, Stephansson O, Gemzell-Danielsson K Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod. 2007 Oct;22(10):2647-52. Epub 2007 Jul 25.
Tangsiriwatthana T, Sangkomkamhang US, Lumbiganon P, Laopaiboon M Paracervical local anaesthesia for cervical dilatation and uterine intervention. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD005056. doi: 10.1002/14651858.CD005056.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;9:CD005056.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
